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DISCUSSION
Dr Kubaska III (Orange, Calif). Dr Schneider and his group
have presented a retrospective study comparing long-term results
of treating vein graft stenoses using cutting balloon angioplasty vs
more traditional treatments of open surgical revision and standard
balloon angioplasty. Cutting balloon angioplasty has been shown
in this study to be superior to standard balloon angioplasty and to
have comparable 4-year stenosis-free patency rates vs open surgical
revision of 62% vs 74%, respectively. These findings indicate that
cutting balloon angioplasty is competitive with open surgical revi-
sion in the initial treatment of infrainguinal vein graft stenosis.
The Achilles heel compromising long-term patency of infrain-
guinal vein bypass grafts is the development of stenoses from
intimal hyperplasia at the anastomotic or mid-graft locations asso-
ciated with vein valves. Using standard duplex imaging surveillance
protocols, stenosis can be localized and scheduled for treatment
prior to graft failure, thereby improving patency and longevity of
the graft.
I have a few questions for the authors. With cutting balloon
technology greatly changing over the period of the study, do you
think that this may have influenced the technical success of these
procedures and ultimately the long-term outcomes of the proce-
dures?
Have you used other types of cutting balloons or scoring
balloons prior to standard balloon angioplasty? At our institution,
we have recently started using the AngioSculpt [AngioScore Inc,
Fremont, Calif], a scoring balloon, to treat stenosis of infrainguinal
cryopreserved vein grafts, which are known to be prone to recur-
rent stenosis with favorable results.
Did you find that lesions in the body of the graft which are
usually associated with vein valves more or less difficult to treat
than anastomotic lesions and why?
And finally, do you think with the addition of antiplatelet
agents such as clopidogrel in conjunction with aspirin, the patency
rates following percutaneous interventions have improved over the
past decade? Could you comment on preprocedural administration
of Plavix [Sanofi-Aventis, Bridgewater, NJ], duration of the anti-
platelet therapy, and in cases where patients do not tolerate long-
term antiplatelet drug administration?
I thank the program committee for the privilege of discussing
this paper and the authors for sending me their manuscript well
before the meeting for my review. Thank you.
Dr Schneider. Balloon angioplasty is definitely better now
than it was in the mid to late ’90s. Part of it is the equipment—the
devices that we have available—and the other is the pharmacolog-
ical manipulation that goes with it. However, vein graft lesions
have not changed. My impression before we did this study was that
balloon angioplasty gives you a great result about a third of the
time and you cannot really figure out why. A third look great after
balloon angioplasty and a third look like you didn’t do anything
and a third look like you ripped it. The nice thing about cutting is
that the vein graft lesion is usually a focal lesion, which is nice for
endo, and by cutting it first it gives you the ability to open it
without ripping it.
So, well what about balloon angioplasty? Results of a very
contemporary series might be better, and if it were, it would
probably be because of statins and antiplatelet agents and other
factors. Basic balloon mechanics have not changed. The results of
balloon angioplasty for vein graft lesions in this series was right in
line withmany series that have been performed in the past 10 years.
I do not think that we will go back to balloon angioplasty for vein
graft lesions. The reason is that the additional risk of cutting
angioplasty is low and because the cutting provides a coordinated
cut whereas the angioplasty will always be a little bit random.
About scoring balloons—the thing I like about the scoring
balloons is that you can get them in longer segments. This is a piece
of metal sort of intertwined around the outside of the balloon.
Maybe that will work nicely for diffuse tibial lesions, but we have
not tried them in the vein graft stenoses.
The lesions in the body of the graft: It is not a huge number
but we looked hard and really could not find a difference between
the different locations of the lesions and how they responded.
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